• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Chelsea Therapeutics International Ltd

+ Add to Watchlist

CHTP:US

4.7600 USD 0.1000 2.15%

As of 20:10:00 ET on 04/16/2014.

Snapshot for Chelsea Therapeutics International Ltd (CHTP)

Open: 4.7200 Day's Range: 4.6000 - 4.8500 Volume: 1,706,550
Previous Close: 4.6600 52wk Range: 1.6800 - 6.8300 1-Yr Rtn: +151.85%

Stock Chart for CHTP

No chart data available.
  • CHTP:US 4.7600
  • 1D
  • 1M
  • 1Y
4.6600
Interactive CHTP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CHTP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2400
Est. EPS (USD) (12/2014) -0.3400
Est. PEG Ratio -
Market Cap (M USD) 373.35
Shares Outstanding (M) 78.43
30 Day Average Volume 3,005,743
Price/Book (mrq) 8.6311
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CHTP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CHTP

Chelsea Therapeutics International Ltd. is a biopharmaceutical development company that acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.

Joseph G OlivetoPresident/CEOWilliam D SchwietermanVP/Chief Medical Officer
Keith W SchmidtVP/Chief Commercial OfficerL Arthur HewittVP/Chief Scientific Officer
More Company Profile & Key Executives for CHTP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil